Different Forms of Tenascin-C with Tenascin-R Regulate Neural Differentiation in Bone Marrow-Derived Human Mesenchymal Stem Cells

Abstract

Mesenchymal stem cells (MSCs) are currently thought to transdifferentiate into neural lineages under specific microenvironments. Studies have reported that the tenascin family members, tenascin-C (TnC) and tenascin-R (TnR), regulate differentiation and migration, in addition to neurite outgrowth and survival in numerous types of neurons and mesenchymal progenitor cells. However, the mechanisms by which TnC and TnR affect neuronal differentiation are not well understood. In this study, we hypothesized that different forms of tenascin might regulate the neural transdifferentiation of human bone marrow-derived mesenchymal stem cells. Human MSCs were cultured in media incorporated with soluble tenascins, or on precoated tenascins. In a qualitative polymerase chain reaction analysis, adding a soluble TnC and TnR mixture to the medium significantly enhanced the expression of neuronal and glial markers, whereas no synaptic markers were expressed. Conversely, in groups of cells treated with coated TnC, hMSCs showed neurite outgrowth and synaptic marker expression. After being treated with coated TnR, hMSCs exhibited neuronal differentiation; however, it inhibited neurite outgrowth and synaptic marker expression. A combination of TnC and TnR significantly promoted hMSC differentiation in neurons or oligodendrocytes, induced neurite formation, and inhibited differentiation into astrocytes. Furthermore, the effect of the tenascin mixture showed dose-dependent effects, and a mixture ratio of 1:1 to 1:2 (TnC:TnR) provided the most obvious differentiation of neurons and oligodendrocytes. In a functional blocking study, integrin a7 and a9b1-blocking antibodies inhibited, respectively, 80% and 20% of mRNA expression by hMSCs in the coated tenascin mixture. In summary, the coated combination of TnC and TnR appeared to regulate neural differentiation signaling through integrin a7 and a9b1 in bone marrow-derived hMSCs. Our findings demonstrate novel mechanisms by which tenascin regulates neural differentiation, and enable the use of cell therapy to treat neurodegenerative diseases.

Histological assessment of human regenerative endodontic procedures (REP) of immature permanent teeth with necrotic pulp/apical periodontitis: A systematic review

“…Nerve regeneration can be explained with different mechanisms: From stem cell differentiation of PDL . From the survival of DPSCs from the remaining dental pulp . From SCAP survival from the apical papilla . From transplantation of bone marrow mesenchymal stem cells during apical bleeding provocation . From collateral reinnervation from the surrounding tissues by sprouting and ingrowth inside the root canal . …”

Nerve regeneration by human corneal stromal keratocytes and stromal fibroblasts

“…Other SF secreted proteins can be categorized into ECM proteins associated with neurite initiation, growth and elongation, topographic guidance and protection from apoptosis, including FN, LAM, CTGF, CYR61, COL6A2, HSPG2, BGN, MGP and TNC65666768. Moreover, matricellular proteins like MMP2, TIMP, GDNF, PDGF, IGFBPs, THBS and complement factor C1R have been reported to promote neurite extension, adhesion, branching and differentiation as well as protection from neurotoxicity69707172.…”

Histologic and Immunohistochemical Findings of a Human Immature Permanent Tooth with Apical Periodontitis after Regenerative Endodontic Treatment

“…During the induction of periapical bleeding by irritating the periapical tissues, mesenchymal stem cells from the bone marrow may be transplanted into the root canal. Bone marrow mesenchymal stem cells can differentiate into neurons and astrocytes under appropriate conditions (38). It has been shown that transplanted bone marrow mesenchymal stem cells into the injured spinal cord of rats could differentiate into neurons and astrocytes and repair spinal cord ischemia injury (39).…”